LOGIN
Corticosteroid Injection Addition to Casting is Superior to Casting Alone for De Quervain's Disease
September 2020
Corticosteroid Injection Addition to Casting is Superior to Casting Alone for De Quervain's Disease
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Methylprednisolone acetate injection with casting versus casting alone for the treatment of De-Quervain's Tenosynovitis: a randomized controlled trial.
J Pak Med Assoc. 2020 Aug;70(8):1314-1318.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
One hundred and seventy-four patients with De Quervain's tenosynovitis were randomized to receive a thumb Spica cast and a corticosteroid injection (1mL of 10 mg) of triamcinolone acetonide and (1mL) lidocaine, or a thumb Spica cast alone to evaluate improvement in pain and function. The primary outcomes of interest included pain on a Visual Analog Scale (VAS) and the Quick Disability of the Arm, ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.